Institutional investors control 48.23% of the outstanding shares in SNSS. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended September 2016, these large investors purchased a net $4.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DAFNA CAPITAL MANAGEMENT LLC Bought 1.1 Million shares of Sunesis Pharmaceuticals I...
CORMORANT ASSET MANAGEMENT LLC Bought 1.0 Million shares of Sunesis Pharmaceuticals I...